Johnson & Johnson Launched onTrumpRx to Offer Discounted Meds
Synopsis
Johnson & Johnson has officially added four of its major medications, including the blood thinner Xarelto and diabetes drug Invokana, to the Trump administration’s TrumpRx platform. Announced on April 24, 2026, the move is part of a landmark deal where J&J will offer "most-favored-nation" pricing to American patients in exchange for an exemption from a 100% tariff on foreign-made pharmaceuticals. Along with listing these discounted meds, J&J has committed $55 billion to boost U.S. manufacturing. Analysts say the move significantly expands the reach of the TrumpRx program, aiming to provide immediate cost relief for millions of uninsured and cash-paying consumers.
The Trump administration now lists four Johnson & Johnson (J&J) prescription drugs on its TrumpRx discount website. It is part of a deal to reduce healthcare costs for Americans in exchange for waivers on expensive U.S. taxes he imposed on foreign drugs.
Key Highlights
- At TrumpRx, J&J is selling Invokana, Invokamet, and Invokamet XR; Xarelto
- The meds are Type 2 diabetes and blood clots
- The deal gives J&J a pass on a 100% duty on patented foreign-made medications
- J&J has committed to $55 billion in U.S.-based R&D and manufacturing
J&Js Lists Four Major Medications
Johnson & Johnson announced the plans to sell four of their best-selling drugs on the TrumpRx. gov platform. Those drugs include diabetes medications Invokana, Invokamet, and Invokamet XR, as well as the blood thinner Xarelto. This rollout comes on the back of a voluntary deal J&J entered into in January 2026 to cut drug prices for U.S. consumers. Patients carry no similar burden when insurance is the payer, as negotiated rates are usually lower than other hospital prices; however, TrumpRx prices are tailor-made for the uninsured or cash payers, with deep discounts intended to match the lowest paid prices of other developed countries.
How and why J&J got in the program, and what deals they landed
The backbone of J&J's participation is an exchange for trade with the US government. According to an April 2026 presidential proclamation, all patented medications made outside of the United States are subject to a 100% statutory tariff. In exchange for these punishing taxes, J&J made two main commitments, adopting Most-Favoured-Nation (MFN) pricing and investing in domestic production. J&J lists on TrumpRx and is granted a three-year exemption from these tariffs, which also allows it to fulfil its pledge of $55 billion in new manufacturing and research facilities in Pennsylvania and North Carolina.
Similar agreements have recently been struck by other Big Pharma companies, such as Pfizer, Eli Lilly, and AstraZeneca, to gain market access in the U.S., making J&J one of many. In these deals, companies will sell their drugs to Medicaid at EU-style prices and offer deep discounts to patients who pay in cash (TrumpRX). The move shields J&J’s highly profitable heart and diabetes divisions from trade penalties, all while presenting the company as a partner in the administration's mission to reduce national healthcare costs.
Expert take
Healthcare analysts see J&J’s inclusion as a huge boost to the TrumpRx platform, which has more than doubled its drug list since February. The administration is hitting some of the worst out-of-pocket costs for people by including a heavy-hitter like Xarelto, one of the most prescribed blood thinners in the world. The prices listed on TrumpRx may still be more than what they usually pay in co-pays for private plans.
FAQs
- What is TrumpRx?
That was on an official government site (TrumpRx.gov) to help patients access significant savings on brand-name medications, often through printable coupons or direct-to-consumer links.
- How much can I save?
The aim is to equalise the price with the Most-Favoured-Nation rate, the best available rate for its selling price from other major developed nations.
- Will the site asks for prescription.?
Yes. All medicines are offered at discounted prices but you still need a prescription from a licensed medical doctor in order to get the medication.
- What makes these drugs cheaper on the website?
Companies such as J&J are told they will be permitted to bring their drugs into the U.S. without having to pay 100% tariffs in return for a price cut
Follow Inspirepreneur Magazine for daily global business news.
At Inspirepreneurs Magazine, covering entrepreneurship, business failures, and the human stories behind the world's most ambitious founders. She writes at the intersection of strategy and storytelling.
